Intellipharmaceutics International Inc.
IPCIQ
$0.00
$0.000.00%
OTC PK
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 400.10K | 159.30K | 69.50K | 83.70K | 79.60K |
| Total Receivables | 268.20K | 601.80K | 479.70K | 268.80K | 268.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 193.60K | 192.40K | 186.10K | 140.00K | 207.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 861.90K | 953.40K | 735.40K | 492.50K | 554.80K |
|
|
|||||
| Total Current Assets | 861.90K | 953.40K | 735.40K | 492.50K | 554.80K |
| Net Property, Plant & Equipment | 703.60K | 781.50K | 859.60K | 938.90K | 881.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 300.00 | 400.00 | 400.00 | 600.00 | 1.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.57M | 1.74M | 1.60M | 1.43M | 1.44M |
|
|
|||||
| Total Accounts Payable | 3.86M | 3.67M | 3.82M | 3.76M | 4.26M |
| Total Accrued Expenses | 7.25M | 6.78M | 6.38M | 5.89M | 5.31M |
| Short-term Debt | 2.18M | 2.16M | 2.16M | 2.16M | 1.96M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 43.10K | 84.50K | 138.10K | 165.40K | 43.40K |
| Total Finance Division Other Current Liabilities | 1.12M | 29.00K | 29.00K | 29.00K | 18.20K |
| Total Other Current Liabilities | 1.12M | 29.00K | 29.00K | 29.00K | 18.20K |
| Total Current Liabilities | 14.44M | 12.72M | 12.53M | 12.01M | 11.59M |
|
|
|||||
| Total Current Liabilities | 14.44M | 12.72M | 12.53M | 12.01M | 11.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 2.18M | 2.16M | 2.16M | 2.16M | 1.96M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.44M | 12.72M | 12.53M | 12.01M | 11.59M |
|
|
|||||
| Common Stock & APIC | 94.27M | 94.27M | 94.27M | 94.27M | 93.82M |
| Retained Earnings | -107.43M | -105.54M | -105.49M | -105.13M | -104.26M |
| Treasury Stock & Other | 284.40K | 284.40K | 284.40K | 284.40K | 284.40K |
| Total Common Equity | -12.88M | -10.99M | -10.93M | -10.58M | -10.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.88M | -10.99M | -10.93M | -10.58M | -10.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.88M | -10.99M | -10.93M | -10.58M | -10.15M |
|
|
|||||